Mpox vaccine for adolescents and eight new medicines receive EMA approval

The European Medicines Agency’s (EMA) human medicines committee has authorised the use of Bavarian Nordic’s mpox vaccine Imvanex for adolescents.

Content-Type:

News Based on facts, either observed and verified directly by the reporter, or reported and verified from knowledgeable sources.

WHO and Ministry of Health officials take a sample from an mpox patient in Mongala, Democratic Republic of the Congo, on 25 March 2023. [© WHO / Katson Maliro]

Euractiv is part of the Trust Project

Catherine Feore Euractiv 20-09-2024 18:35 2 min. read Content type: News

Euractiv is part of the Trust Project

Facebook X LinkedIn Mail

Donec et orci aliquet nisl suscipit molestie sed sit amet tortor. Duis vel urna ac mi sollicitudin lacinia mollis sit amet lorem. Sed finibus erat nec libero scelerisque fringilla. Morbi at orci sed urna vulputate vulputate. Nulla facilisi. Donec et orci aliquet nisl suscipit molestie sed sit amet tortor.

Want to keep reading?

Get a subscription on Euractiv Pro and elevate your political insight!

Discover Euractiv Pro
For corporations

Updated: 03-10-2024

Mpox vaccine for adolescents and eight new medicines receive EMA approval

More from this section

More from this author

Mpox vaccine for adolescents and eight new medicines receive EMA approval

Topics

More from this section

More from this author

Subscribe to our newsletters